vs
Side-by-side financial comparison of Precipio, Inc. (PRPO) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.
Precipio, Inc. is the larger business by last-quarter revenue ($6.8M vs $5.0M, roughly 1.4× cbdMD, Inc.). Precipio, Inc. runs the higher net margin — 7.7% vs -5.6%, a 13.4% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs -1.9%). Precipio, Inc. produced more free cash flow last quarter ($291.0K vs $-977.3K). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs 7.1%).
Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.
cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.
PRPO vs YCBD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $6.8M | $5.0M |
| Net Profit | $526.0K | $-283.1K |
| Gross Margin | 45.9% | 59.8% |
| Operating Margin | 7.9% | -5.7% |
| Net Margin | 7.7% | -5.6% |
| Revenue YoY | 28.4% | -1.9% |
| Net Profit YoY | 244.1% | -1975.7% |
| EPS (diluted) | $0.36 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.8M | $5.0M | ||
| Q3 25 | $6.9M | $4.7M | ||
| Q2 25 | $5.6M | $4.6M | ||
| Q1 25 | $4.9M | $4.7M | ||
| Q4 24 | $5.3M | $5.1M | ||
| Q3 24 | $5.3M | $4.6M | ||
| Q2 24 | $4.5M | $5.2M | ||
| Q1 24 | $3.5M | $4.4M |
| Q4 25 | $526.0K | $-283.1K | ||
| Q3 25 | $-79.0K | $-680.0K | ||
| Q2 25 | $74.0K | $-895.3K | ||
| Q1 25 | $-884.0K | $-480.8K | ||
| Q4 24 | $-365.0K | $15.1K | ||
| Q3 24 | $-626.0K | $-152.8K | ||
| Q2 24 | $-1.2M | $459.7K | ||
| Q1 24 | $-2.1M | $-3.0M |
| Q4 25 | 45.9% | 59.8% | ||
| Q3 25 | 43.6% | 58.8% | ||
| Q2 25 | 43.2% | 61.5% | ||
| Q1 25 | 43.6% | 62.3% | ||
| Q4 24 | 49.8% | 66.5% | ||
| Q3 24 | 43.1% | 53.9% | ||
| Q2 24 | 38.1% | 65.8% | ||
| Q1 24 | 26.5% | 59.0% |
| Q4 25 | 7.9% | -5.7% | ||
| Q3 25 | -0.9% | -14.5% | ||
| Q2 25 | -14.6% | -19.6% | ||
| Q1 25 | -17.5% | -10.2% | ||
| Q4 24 | -6.3% | -1.7% | ||
| Q3 24 | -11.3% | -6.9% | ||
| Q2 24 | -26.8% | -7.4% | ||
| Q1 24 | -59.6% | -35.4% |
| Q4 25 | 7.7% | -5.6% | ||
| Q3 25 | -1.1% | -14.4% | ||
| Q2 25 | 1.3% | -19.4% | ||
| Q1 25 | -18.0% | -10.1% | ||
| Q4 24 | -6.9% | 0.3% | ||
| Q3 24 | -11.9% | -3.4% | ||
| Q2 24 | -27.1% | 8.9% | ||
| Q1 24 | -59.8% | -68.8% |
| Q4 25 | $0.36 | — | ||
| Q3 25 | $-0.05 | — | ||
| Q2 25 | $0.05 | — | ||
| Q1 25 | $-0.59 | — | ||
| Q4 24 | $-0.22 | — | ||
| Q3 24 | $-0.42 | — | ||
| Q2 24 | $-0.83 | $-0.15 | ||
| Q1 24 | $-1.46 | $-1.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.7M | $3.4M |
| Total DebtLower is stronger | $83.0K | — |
| Stockholders' EquityBook value | $14.6M | $9.0M |
| Total Assets | $21.3M | $11.8M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.7M | $3.4M | ||
| Q3 25 | $2.3M | $2.3M | ||
| Q2 25 | $1.1M | $1.1M | ||
| Q1 25 | $1.0M | $1.8M | ||
| Q4 24 | $1.4M | $2.0M | ||
| Q3 24 | $1.1M | $2.5M | ||
| Q2 24 | $1.3M | $2.4M | ||
| Q1 24 | $776.0K | $2.1M |
| Q4 25 | $83.0K | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $383.0K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.6M | $9.0M | ||
| Q3 25 | $13.7M | $7.2M | ||
| Q2 25 | $12.3M | $6.1M | ||
| Q1 25 | $11.7M | $665.8K | ||
| Q4 24 | $12.1M | $1.8M | ||
| Q3 24 | $11.9M | $2.0M | ||
| Q2 24 | $12.1M | $3.0M | ||
| Q1 24 | $12.8M | $3.1M |
| Q4 25 | $21.3M | $11.8M | ||
| Q3 25 | $21.2M | $10.4M | ||
| Q2 25 | $18.8M | $9.9M | ||
| Q1 25 | $17.8M | $10.9M | ||
| Q4 24 | $17.0M | $11.5M | ||
| Q3 24 | $17.0M | $10.6M | ||
| Q2 24 | $17.3M | $13.8M | ||
| Q1 24 | $16.6M | $14.6M |
| Q4 25 | 0.01× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $366.0K | $-812.5K |
| Free Cash FlowOCF − Capex | $291.0K | $-977.3K |
| FCF MarginFCF / Revenue | 4.3% | -19.5% |
| Capex IntensityCapex / Revenue | 1.1% | 3.3% |
| Cash ConversionOCF / Net Profit | 0.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $359.0K | $-2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $366.0K | $-812.5K | ||
| Q3 25 | $10.0K | $-240.7K | ||
| Q2 25 | $353.0K | $-704.2K | ||
| Q1 25 | $-44.0K | $-189.5K | ||
| Q4 24 | $565.0K | $-317.9K | ||
| Q3 24 | $41.0K | $167.4K | ||
| Q2 24 | $500.0K | $289.8K | ||
| Q1 24 | $-667.0K | $-704.1K |
| Q4 25 | $291.0K | $-977.3K | ||
| Q3 25 | $-44.0K | $-243.6K | ||
| Q2 25 | $294.0K | $-705.7K | ||
| Q1 25 | $-182.0K | $-205.0K | ||
| Q4 24 | — | $-482.3K | ||
| Q3 24 | $-68.0K | $157.4K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-708.7K |
| Q4 25 | 4.3% | -19.5% | ||
| Q3 25 | -0.6% | -5.2% | ||
| Q2 25 | 5.2% | -15.3% | ||
| Q1 25 | -3.7% | -4.3% | ||
| Q4 24 | — | -9.4% | ||
| Q3 24 | -1.3% | 3.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -16.2% |
| Q4 25 | 1.1% | 3.3% | ||
| Q3 25 | 0.8% | 0.1% | ||
| Q2 25 | 1.0% | 0.0% | ||
| Q1 25 | 2.8% | 0.3% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | 2.1% | 0.2% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 0.70× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.77× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -21.06× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.63× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRPO
Segment breakdown not available.
YCBD
| Sales Channel Directly To Consumer | $3.6M | 72% |
| Sales Channel Through Intermediary | $1.4M | 28% |
